Survival benefit and dynamics of CD8<sup>+</sup> T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy <i>vs</i>. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study.

Front Immunol · 2026 · PMC13061859 · PMID 41972149

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant

49.55%), although these differences did not reach statistical significance (all P > 0.05; Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Survival benefit and dynamics of CD8&lt;sup&gt;+&lt;/sup&gt; T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy &lt;i&gt;vs&lt;/i&gt;. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study.

The sentences

Survival benefit and dynamics of CD8<sup>+</sup> T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy <i>vs</i>. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study.